Medico Remedies Ltd

Medico Remedies Ltd

$MEDICOPharmaceuticalsNSEBSE

Medico Remedies Ltd (MEDICO) last traded at ₹41.5, a market capitalisation of ₹345 crore, on a P/E of 25.0. Over the past 52 weeks the stock has ranged between ₹30.2 and ₹57. Medico Remedies Ltd last reported results for the quarter ended Jun 2026, with sales of ₹69.4 crore and net profit of ₹2.52 crore. Figures are as of 25 Aug 2026 and are not real time.

Medico Remedies Ltd share price and key metrics

Current price
₹41.5
Market cap
₹345 cr
Stock P/E
25.0
Book value
₹9.1
ROE
19.0%
ROCE
23.1%
Dividend yield
0.00%
52w high / low
57.0/30.2

Metrics as of 25 Aug 2026. Not real time.

Medico Remedies Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹69.4 cr, up 81.4% from ₹38.25 cr a year earlier. Net profit was ₹2.52 cr, up 38.5% year on year.

Medico Remedies Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales39.3539.4941.338.2552.6458.6856.8169.4
Expenses36.9436.3834.6435.4349.9154.3549.6666.1
Operating profit2.413.116.662.822.734.337.153.3
OPM %6.12%7.88%16.13%7.37%5.19%7.38%12.59%4.76%
Other income0.681.430.290.661.720.682.871.17
Interest0.210.280.490.280.240.390.90.41
Depreciation0.750.760.770.770.730.790.80.72
Profit before tax2.133.55.692.433.483.838.323.34
Tax %27.23%25.14%23.90%25.51%25.86%25.07%29.69%24.55%
Net profit1.552.624.341.822.572.875.862.52
EPS (₹)0.190.320.520.220.310.350.710.30

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Medico Remedies Ltd annual results

Medico Remedies Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales122121140145151206238
Operating profit571013151718
OPM %4.3%6%7%9%10%8%7%
Net profit3578101314
EPS (₹)0.310.580.871.001.221.581.67

TTM is the trailing twelve months to the most recent quarter.

Medico Remedies Ltd growth and returns

Compounded Sales Growth
10 Years
12%
5 Years
11%
3 Years
14%
TTM
50%
Compounded Profit Growth
10 Years
28%
5 Years
38%
3 Years
22%
TTM
34%
Stock Price CAGR
10 Years
%
5 Years
32%
3 Years
-19%
1 Year
8%
Return on Equity
10 Years
14%
5 Years
17%
3 Years
18%
Last Year
19%

Medico Remedies Ltd shareholding pattern

Promoters held 61.38% at Jun 2026, down from 62.59% at Jun 2025. FIIs 0.08% and DIIs 0.00%.

Medico Remedies Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters73.34%66.83%63.79%62.59%61.38%61.38%61.38%61.38%
FIIs0.22%0.39%0.11%0.07%0.30%0.49%0.03%0.08%
DIIs0.97%0.78%0.01%0.01%0.01%0.00%0.00%0.00%
Public25.47%32.00%36.08%37.33%38.30%38.13%38.60%38.55%
No. of shareholders12,88714,10415,42416,47418,50316,56216,18915,863

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Medico Remedies Ltd corporate filings

  • Clarification On Price MovementCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: The company has issued a formal clarification in response to recent fluctuations in its…

    Read the full analysis
  • Financial Results For The Quarter Ended On 30Th June, 2026Resulthigh impact
    Filing PDF

    Cruxal's analysis: Medico Remedies Limited reported strong Q1 FY27 performance with revenue from operations…

    Read the full analysis
  • Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. To consider and approve, ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Medico Remedies Limited has issued a formal notice for a Board of Directors meeting…

    Read the full analysis
  • Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderCompany Updatehigh impact
    Filing PDF

    Cruxal's analysis: Medico Remedies Limited has secured a government supply order from PROMESE/CAL, Dominican…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Medico Remedies Ltd

Cruxal reads every Medico Remedies Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.